Pearls of Wisdom
Deloitte and Thomson Reuters Asses Top 12 Life Science Companies
Deloitte and Thomson Reuters recently performed their annual R&D-ROI balance by assessing the finances of the top 12 life sciences companies. The study reports a mixed performance picture in 2012 relative to the previous year. More drugs were approved between 2011...
INpact Meeting January 23, 2013
Join Pearl staff at the first INpact lunch meeting of 2013 on Wednesday, January 23rd. INpact is focused on supporting the medical device industry in Indiana. Please attend the lunch to network and learn more about the new bimonthly meeting format. Date: January...
FDA/Xavier PharmaLink Conference to Highlight FDASIA Legislation in March
Xavier University is hosting the FDA/Xavier PharmaLink Conference March 11-14. The event brings together industry experts and the FDA to discuss and solve challenges in the field. The focus of the meeting revolves around the FDA Safety and Innovation Act (FDASIA)...
Insight on the Potential Impact of Standardized Clinical Data Terminology on Clinical Studies
In a recent article in Applied Clinical Trails Online, author Wayne Kubick describes the changes that could occur in conducting future clinical trials. Kubick highlights Prescription Drug User Fee Act (PDUFA V), which calls upon the FDA to establish a standardized...
Pearl Pathways year end holiday hours
Our office will be closed for the holidays December 24th, 25th, 31st and also on January 1st. There will be no IRB Board meeting the week of December 24th due to the holidays. We will resume IRB reviews the week of December 31st and hold a Board meeting on January...